Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Adaptive myelination from fish to man.
Treatment of multiple sclerosis with the pregnancy hormone estriol.
Enhancement of axonal potassium conductance reduces nerve hyperexcitability in an in vitro model of oxaliplatin-induced acute neuropathy.
Spectrum of nontraumatic myelopathies in Ethiopian patients: hospital-based retrospective study.
RTL therapy for multiple sclerosis: a Phase I clinical study.
Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.
Imovane: Best Online Pharmacy
Biogen Idec completes purchase of full rights and control of Tysabri®
Alemtuzumab for the Treatment of Multiple Sclerosis
Visualization of myelination in GFP-transgenic zebrafish.
Recurrent brainstem lesions mimicking infarctions in an elderly patient with neuromyelitis optica spectrum disorder.
Characterization of CD56bright NK cells in daclizumab HYP-treated RRMS patients
Genzyme’s once-daily, oral AUBAGIO® approved in Australia for treatment of relapsing multiple sclerosis
Zebrafish myelination: a transparent model for remyelination?
UCSF Seminar: "Dynamics of Retina Damage in Acute Optic Neuritis"
American Society for Cell Biology Annual Meeting
Alemtuzumab and multiple sclerosis: therapeutic application.
Klotho Is a Neuroprotective and Cognition-Enhancing Protein.
Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients.
Changes of serum sICAM-1 and MMP-9 induced by rIFNbeta-1b treatment in relapsing-remitting MS.
The interaction of Q analogs, particularly hydroxydecyl benzoquinone (idebenone), with the respiratory complexes of heart mitochondria.
Ruxolitinib synergizes with DMF to kill via BIM+BAD-induced mitochondrial dysfunction and via reduced SOD2/TRX expression and ROS.
Oracle Cladribine in Early Multiple Sclerisis (MS) (ORACLE MS)
Plasma osteopontin levels are associated with disease activity in the patients with multiple sclerosis and neuromyelitis optica.
Incorporating Alcohol Pharmacotherapies Into Medical Practice

Pages